Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	15.87	33.51	25.18
Cash & Short-Term Investments	25.09	33.51	25.18
Cash Growth	13.20%	33.10%	-
Accounts Receivable	19.4	15.16	15.61
Other Receivables	1.29	1.29	-
Receivables	20.77	16.84	17.14
Inventory	6.38	4.28	6.12
Prepaid Expenses	1.05	1.55	0.38
Other Current Assets	1.51	1.05	0.84
Total Current Assets	54.81	57.22	49.65
Property, Plant & Equipment	26.43	23.78	18.38
Long-Term Investments	29.52	23.43	7.39
Other Intangible Assets	1.66	1.7	1.86
Long-Term Deferred Tax Assets	5.16	4.7	4.08
Other Long-Term Assets	7.67	5.72	3.39
Total Assets	125.24	116.54	84.75
Accounts Payable	0.3	0.36	0.12
Accrued Expenses	8.16	9.65	6.77
Current Portion of Leases	0.69	0.21	0.49
Current Income Taxes Payable	2.84	5.05	2.1
Current Unearned Revenue	0.08	0.08	0.17
Other Current Liabilities	2.64	4.7	2.59
Total Current Liabilities	14.72	20.05	12.24
Long-Term Leases	1.1	0.2	0.12
Long-Term Unearned Revenue	0.19	0.21	0.12
Other Long-Term Liabilities	10.76	17.61	0.06
Total Liabilities	26.77	38.07	12.54
Common Stock	0.09	0.08	0.06
Additional Paid-In Capital	134.3	68.18	32.8
Retained Earnings	-70.26	-82.44	10.06
Comprehensive Income & Other	-0.95	-1.64	-0.39
Total Common Equity	63.18	-15.83	42.52
Minority Interest	35.3	29.78	29.7
Shareholders' Equity	98.47	78.47	72.22
Total Liabilities & Equity	125.24	116.54	84.75
Total Debt	1.8	0.41	0.61
Net Cash (Debt)	23.3	33.1	24.56
Net Cash Growth	7.40%	34.76%	-
Net Cash Per Share	0.28	0.50	0.32
Filing Date Shares Outstanding	85.82	85.42	63.59
Total Common Shares Outstanding	85.77	76.6	63.59
Working Capital	40.09	37.17	37.41
Book Value Per Share	0.74	-0.21	0.67
Tangible Book Value	61.52	-17.53	40.67
Tangible Book Value Per Share	0.72	-0.23	0.64
Buildings	19.12	12.29	10.84
Machinery	10.26	7.39	5.69
Construction In Progress	0.39	7.88	4.85
Leasehold Improvements	-	-	0.33

Source: S&P Capital IQ. Standard template. Financial Sources.